Cite
HARVARD Citation
Hemmi, T. et al. (2022). Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology. Vaccine. 40 (41), pp. 5892-5903. [Online].